Manfred Rüdiger, Ariceum Therapeutics CEO
German radiopharma biotech acquires British startup in tiny deal
Two private biotechs pulled off a small merger on Thursday.
Berlin-based Ariceum Therapeutics acquired the UK’s Theragnostics, the companies announced, for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
